new medicines

Boehringer to Expand Greek Production Site for New Medicines

German drugmaker Boehringer Ingelheim is investing €120 million in an upgrade and expansion of its facility in Koropi, Greece, that will increase the company's capacity to produce existing and new medicines. Main disease areas, Boehringer said, include cardio-renal-metabolic (CRM) diseases, mental health, and pulmonary fibrosis.

Biogen Wins EU Backing for Big New MS Drug Hope

Antibiotics Crisis Prompts Rethink on Risks, Rewards

FDA Head, Company CEOs Cheer Bumper Haul of New Drugs

Drug Industry Bets on New Blockbusters in 2013

Top-Selling Drugs for Ultra-Rare Diseases

Entering the Age of the $1 Million Medicine

US FDA New Drug Approvals Hit 16-Year High in 2012